Diacriptin 0.8Mg Tablet

Diacriptin 0.8Mg Tablet is used in the treatment of Parkinson’s disease. It can control symptoms of hyperprolactinemia including excess production of breastmilk, hypogonadism, infertility and a number of disruptions in the menstrual cycle. The drug helps to control the abnormally high production of growth hormones, and can inhibit the growth of certain tumours that release excess amounts of prolactin.

Diacriptin 0.8Mg Tablet has strong dopaminergic effects and works by activating dopamine D2 receptors and also as a partial agonist of D1 receptors. Postsynaptic activation of D2 receptors lead to antiparkinson effects whereas presynaptic activation of D2 receptors lead to neuroprotective effects. Activation of D2 receptors in the nigrostriatal pathway is responsible for improving coordinated muscle movements in people with Parkinson’s. Diacriptin 0.8Mg Tablet also has prolactin inhibitory effect by inhibiting lactotrophic cells in the anterior pituitary from secreting prolactin due to increased production of dopamine.

Diacriptin 0.8Mg Tablet may cause some side effects including nausea, light-headedness, dizziness, drowsiness, vomiting, irregular heartbeat, hypotension, vasospasms, insomnia, depression and fatigue. Consult your doctor immediately if you experience any of the more serious side effects like fainting, hallucinations, mental or mood changes like anxiety, paranoia, or confusion, swollen feet or ankles, vomit containing blood or particles which look like coffee grounds, impaired vision, chest pain, abnormal coloured stool, breathing problems, numbness on one side of body and a persistent runny nose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

• Female Infertility

• Type 2 Diabetes

• Acromegaly

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

• Nausea

• Vomiting

• Headache

• Dizziness

• Fatigue

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

• Is It safe with alcohol?

  D-bro 2.5mg tablet may cause excessive drowsiness and calmness with alcohol.

• Are there any pregnancy warnings?

  D-bro 2.5mg tablet is probably safe to use during pregnancy.
  Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.

• Are there any breast-feeding warnings?

  D-bro 2.5mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Caution is advised when driving or operating machinery.

• Does this affect kidney function?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Diacriptin 0.8Mg Tablet , and hence can be used as its substitute.

• D-Bro 0.8Mg Tablet

  Zyphar s Pharmaceuticals Pvt Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

The active constituent of this medication is an ergot derivative that works as a dopamine D2 agonist. It exhibits antiparkinson and lactation inhibiting effect by selectively binding to dopamine D2 receptors in the CNS. This inhibits adenylyl cyclase which prevents signal transduction mediated via cAMP and results in an inhibition of neurotransmission.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Endocrinologist before using this medicine.

• Bromocryptine-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 28 May 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/bromocryptine

• Bromocryptine-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 28 May 2022].Available from:

  https://go.drugbank.com/drugs/DB01200